{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:58:54Z","timestamp":1767985134417,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.3816\/clm.2000.s.010","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T21:01:57Z","timestamp":1221166917000},"page":"S51-S55","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Bexarotene and DAB389IL-2 (Denileukin Diftitox, ONTAK) in Treatment of Cutaneous T-Cell Lymphomas: Algorithms"],"prefix":"10.3816","volume":"1","author":[{"given":"Madeleine","family":"Duvic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2000.s.010_bib1","first-page":"725","article-title":"Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.3816\/CLM.2000.s.010_bib2","first-page":"276","article-title":"Mycosis fungoides and the Sezary syndrome","volume":"26","author":"Kim","year":"1999","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2000.s.010_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2000.s.010_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0889-8588(18)30057-1","article-title":"Topical treatment of early cutaneous T-cell lymphoma","volume":"9","author":"Ramsay","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2000.s.010_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0190-9622(92)70212-X","article-title":"Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy","volume":"27","author":"Heald","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.010_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-121-8-199410150-00007","article-title":"Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome)","volume":"121","author":"Bunn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2000.s.010_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8635(05)70155-8","article-title":"Emerging new therapies for cutaneous T-cell lymphoma","volume":"18","author":"Duvic","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.3816\/CLM.2000.s.010_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1096-8652(199805)58:1<87::AID-AJH18>3.0.CO;2-2","article-title":"DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma","volume":"58","author":"Duvic","year":"1998","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2000.s.010_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0190-9622(98)70403-7","article-title":"Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides","volume":"39","author":"Saleh","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.010_bib10","first-page":"1658","article-title":"A phase I study of LGD1069 in adults with advanced cancer","volume":"5","author":"Rizvi","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2000.s.010_bib11","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V79.10.2547.bloodjournal79102547","article-title":"Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor","volume":"79","author":"LeMaistre","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.010_bib12","first-page":"536","article-title":"Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group","volume":"69","author":"Thomsen","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.3816\/CLM.2000.s.010_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1995.13.1.257","article-title":"Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome","volume":"13","author":"Kuzel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.s.010_bib14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0190-9622(96)90282-0","article-title":"Combined modality therapy for cutaneous T-cell lymphoma","volume":"34","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.010_bib15","article-title":"Pivotal phase III trial of two dose levels of DAB389IL-2 (ONTAK) for the treatment of cutaneous T cell lymphoma","author":"Olsen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.s.010_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32","article-title":"Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.3816\/CLM.2000.s.010_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0190-9622(96)90683-0","article-title":"Photopheresis therapy for cutaneous Tcell lymphoma","volume":"35","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.010_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-9343(81)90107-8","article-title":"Septicemic complications of the cutaneous T-cell lymphomas","volume":"71","author":"Posner","year":"1981","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2000.s.010_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","article-title":"Central hypothyroidism associated with retinoid X receptor-selective ligands","volume":"340","author":"Sherman","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511702809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511702809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T02:41:55Z","timestamp":1588905715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511702809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":19,"alternative-id":["S1526965511702809"],"URL":"https:\/\/doi.org\/10.3816\/clm.2000.s.010","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}